Human trial of coronavirus vaccine begins in Australia

Daniel Fowler
July 14, 2020

A COVID-19 vaccine under development by Australia's University of Queensland (UQ) has commenced human trials, officials announced Monday.

The very first stage of research on the vaccine at Sechenov University involved a group of 18 volunteers and the second group involved 20 volunteers.

The ministry "hopes to finalize the trials. before fall", it added.

"... An in-ward treatment of the first group of volunteers, who were tested for the safety and tolerability of the vaccine, will end on July 15", the TASS agency quoted Russian Defence Ministry as saying. There are several hurdles to be passed in the search for any vaccine.

For most of its victims, the coronavirus causes mild or moderate symptoms, such as fever and cough that clear up in two to three weeks after a combination of treatment therapy, leading to the recovery of nearly six million sufferers. And, if everything goes well, the next stage would involve a larger group of people from different ages to determine the efficacy of the vaccine. The document of the World Health Organisation on COID-19 vaccine also states the same.

Finding a cure (vaccine) for the disease is the only way out, health experts say.

The study was created to test the efficacy of COVID-19 potential vaccine known as "Gam-COVID-Vac Lyo", and, purportedly, included 9 volunteers in its first group, and an additional 9 in its second group during the first phase of trials.

Realme’s next smartphone will come with a huge 6,000mAh battery
Since both phones have been launched globally, the only piece that's missing from the puzzle is Realme C11 and 6i price in India. A few months ago, a 6,000mAh Lithium-Ion Polymer Battery by Realme was spotted on TUV Rheinland's database.

The participants will have to stay isolated for four weeks to avoid other infections, after which they will be monitored for half a year.

Minister of Higher Education, Science, Research and Innovation (MHESI) Suvit Maesincee, said today he was informed by the Faculty of Medicine, Chulalongkorn University, and the National Research Council of Thailand of promising results in an MRNA vaccine trial for COVID-19 on monkeys, carried out by the National Primate Research Center of Thailand.

"On Monday, July 13, the second group of volunteers, who are tested for the efficiency and immunogenicity of the vaccine, will be injected with the second component of the vaccine against the coronavirus", the agency further said.

Russian Federation has reported more than 732,000 coronavirus illnesses and more than 11,000 deaths as of Monday, a tally by Johns Hopkins University shows.

There are at least 21 vaccines now under key trials, according to the World Health Organisation (WHO). AIIMS New Delhi, and AIIMS Patna will start the initial part of Human trials of the vaccine.

The Russian vaccine is not the only candidate on the market.

Other reports by

Discuss This Article

FOLLOW OUR NEWSPAPER